Universal Biosensors, Inc., through its subsidiaries, designs and develops electrochemical cells (strips) used in conjunction with point-of-use devices used in healthcare (point-of-care), wine, food, and agriculture industries in Australia, the Americas, Europe, and internationally. The company manufactures and distributes Prothrombin Time International Normalized Ratio coagulation test strips and Xprecia Stride and Xprecia Prime medical devices to monitor the effect of the anticoagulant therapy warfarin; and Sentia wine testing products, such as free SO2, malic acid, glucose, fructose, total acid, and titratable acidity. It also offers non-diagnostic laboratory services and performs coagulation testing services. The company has a license agreement with LifeScan Global Corporation to develop a test strip and a meter to be used for the detection and monitoring of diabetes in non-humans. Universal Biosensors, Inc. was incorporated in 2001 and is based in Rowville, Australia.
| 0.12 | |
| 0.12 | |
| - | |
| 0.12 | |
| 0.12 | |
| 0.12-0.3 | |
| 35 768 K | |
| 298 M | |
| 7 080 K | |
| -0.02 | |
| 1.012 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Investors are disappointed there is no imminent takeover in the offing for the maker of Assassin’s Creed. Shares in Ubisoft Entertainment the developer behind the popular videogame franchise, fell m...
Shares of French videogame publisher Ubisoft Entertainment have slumped so far this year. Citi Research says there are plenty of reasons to snap up the stock right now.
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
